초록접수 현황
| 20F-103 | 구연 발표 |
Outcomes of Prophylactic Endosuture Aneurysm Repair in Aortic Aneurysm with Hostile Landing Zone
Ha Lee¹, Myeong su Kim¹, Wan Kee Kim², Seungjun Song², Tae-Hoon Kim¹, Kwang-Hun Lee³, Suk-Won Song¹, Kyung-Jong Yoo⁴
¹ Department of Thoracic and Cardiovascular Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea
² Department of Thoracic and Cardiovascular Surgery, Yongin Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea
³ Department of Radiology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea
⁴Department of Thoracic and Cardiovascular Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea
Purpose : To review clinical outcomes of prophylactic Endosuture Aneurysm Repair(ESAR, EndoAnchor®) during Endovascular Aortic Repair(EVAR) and Thoracic Endovascular Aortic Repair(TEVAR).
Methods : Retrospectively 22 patients who underwent EVAR/TEVAR with prophylactic ESAR(February, 2018 to August, 2020) were analyzed. 20(90.9%) patients had severe comorbidities (ASA score≥3). In EVAR with ESAR(n=14), 12(85.7%) patients had conical neck, 11(78.6%) patients had short neck, 6(42.9%) patients had angulated neck, and 10(71.4%) patients had mural thrombosed neck. In TEVAR with ESAR(n=8), all of them had short landing zone and 5(62.5%) patients had mural thrombosed landing zone. Endoleaks were assessed by final angiography immediately after endovascular treatments and by postoperative follow-up computed tomography(CT)s.
Results : Total procedure time was mean 114.59min. There was no mortality after endovascular treatments and 21(95.5%) patients are visiting outpatient departments. Total 16(72.7%) patients had follow-up CTs. No stent migration was found. Mean 7.7 EndoAnchor®s were implanted. In EVAR with ESAR, 11(78.6) patients had no endoleaks immediately after endovascular treatments. 2 of 3 patients who had endoleaks resolved at follow-up CTs. 2 of 11 patients who had no endoleaks had newly developed endoleaks at follow-up CTs and 1 patient had reintervention due to endoleak. In TEVAR with ESAR, 7(87.5%) patients had no endoleaks after endovascular treatments. 1 patient who had type Ib endoleak resolved at follow-up CT and 1 patient had newly developed endoleak.
Conclusion : Prophylactic ESAR is helpful in endovascular treatment of Aortic aneurysm with hostile landing zone. ESAR can prevent stent migration and endoleaks.
Methods : Retrospectively 22 patients who underwent EVAR/TEVAR with prophylactic ESAR(February, 2018 to August, 2020) were analyzed. 20(90.9%) patients had severe comorbidities (ASA score≥3). In EVAR with ESAR(n=14), 12(85.7%) patients had conical neck, 11(78.6%) patients had short neck, 6(42.9%) patients had angulated neck, and 10(71.4%) patients had mural thrombosed neck. In TEVAR with ESAR(n=8), all of them had short landing zone and 5(62.5%) patients had mural thrombosed landing zone. Endoleaks were assessed by final angiography immediately after endovascular treatments and by postoperative follow-up computed tomography(CT)s.
Results : Total procedure time was mean 114.59min. There was no mortality after endovascular treatments and 21(95.5%) patients are visiting outpatient departments. Total 16(72.7%) patients had follow-up CTs. No stent migration was found. Mean 7.7 EndoAnchor®s were implanted. In EVAR with ESAR, 11(78.6) patients had no endoleaks immediately after endovascular treatments. 2 of 3 patients who had endoleaks resolved at follow-up CTs. 2 of 11 patients who had no endoleaks had newly developed endoleaks at follow-up CTs and 1 patient had reintervention due to endoleak. In TEVAR with ESAR, 7(87.5%) patients had no endoleaks after endovascular treatments. 1 patient who had type Ib endoleak resolved at follow-up CT and 1 patient had newly developed endoleak.
Conclusion : Prophylactic ESAR is helpful in endovascular treatment of Aortic aneurysm with hostile landing zone. ESAR can prevent stent migration and endoleaks.
첨부파일 : Table and Figure_ESAR.docx
책임저자: Suk-Won Song
Department of Thoracic and Cardiovascular Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea
발표자: Ha Lee, E-mail : manofwill@yuhs.ac